https://www.selleckchem.com/pr....oducts/alkbh5-inhibi
012). Patients with a marked "dawn" phenomenon exhibited a lower probability for low (4.4 mmol/L) and a higher probability of high values (7.2 mmol/L) during the dawn period (all values .01). We observe substantial interindividual heterogeneity in the "dawn" phenomenon. However, widely different empirically derived basal insulin infusion profiles appear appropriate for individual patients, as indicated by similar plasma glucose concentrations, mainly in the target range, during a 24-hour fasting period.
Like
Comment
Share
